Hims GLP-1 Reviews: Is It Worth It, What Does It Really Cost, and Who Should Skip It?
Verified pricing, real outcome data from 13,458 tracked customers, side effect reality check, the Novo Nordisk lawsuit explained, and every question we’ve seen people ask on Reddit, Trustpilot, and Bing — answered here.
Disclosure: Some links on this site are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you. Thank you for supporting our site.·For informational purposes only—not medical advice.

Hims GLP-1 Reviews: The Bottom Line
If you’re reading Hims GLP-1 reviews trying to figure out whether this is legit, what the risks and tradeoffs actually are, and whether it’s worth your money — here’s the short version.
Hims is a solid choice if you want fast, no-insurance-needed access to GLP-1 weight loss treatment at a transparent price. Their compounded semaglutide injectable starts at $199/month with a 6-month prepaid plan ($1,194 upfront), and their own data from over 13,000 customers shows an average weight loss of about 20 pounds in six months. Signup takes minutes. Medication ships to your door. No doctor’s office. No insurance headaches.
Hims is NOT the right choice if you need insurance to cover the cost, want intensive hands-on coaching, or are only comfortable with FDA-approved brand-name medications. (We’ll explain that distinction — and why it matters — below.)
The one thing you need to know first: Hims’ most affordable GLP-1 option is a compounded version of semaglutide. Compounded medications are prepared by licensed pharmacies, but they have not been reviewed or approved by the FDA as finished products. Compounded GLP-1s are not FDA-approved products and should not be described as “the same as” Wegovy or Ozempic. The FDA has raised specific concerns about compounded GLP-1 drugs marketed for weight loss. That doesn’t automatically make them unsafe — but it does mean you should understand exactly what you’re getting. This page will show you how to verify it.
Who we’d recommend Hims for: Someone who’s done their homework on GLP-1s, wants a convenient all-digital experience, and values price transparency over hand-holding. If that’s you, the rest of this page confirms what you’re hoping is true — with proof.
Check If You Qualify on Hims — Free AssessmentWhat follows is everything we found after verifying Hims’ pricing, analyzing thousands of real user reviews, and cross-referencing their claims against FDA guidance and published clinical data. We cover pricing (the real numbers, not the marketing ones), what you actually receive, side effects, the compounding controversy, cancellation, and every question we’ve seen people ask on Reddit, Trustpilot, and Bing. If something would send you back to search for more answers, we’ve already answered it here.
Best for
Cash-pay customers who want fast, all-digital GLP-1 access without insurance headaches
Real starting cost
$199/mo (6-month plan = $1,194 paid upfront) for compounded semaglutide injections
Not for
Anyone who needs insurance coverage, intensive coaching, or only FDA-approved brand-name medication
Hims GLP-1 at a Glance: The Numbers That Matter
Before we get into details, here’s the snapshot. This table covers the key facts we verified directly on Hims.com.
| Category | What We Found |
|---|---|
| Medication options | Compounded semaglutide injections, oral medication kits, branded GLP-1s (Zepbound, generic liraglutide, and others) |
| Lowest GLP-1 injectable price | $199/mo with a 6-month plan — that’s $1,194 paid upfront |
| Lowest oral kit price | $69/mo with a 10-month plan — that’s $690 paid upfront |
| Average reported weight loss | 20.9 lbs (10.3% body weight) in 6 months for injectable GLP-1 users; 14.1 lbs (8.4%) for oral kit users |
| Time from signup to medication | ~1–2 weeks (24–48 hr provider review, 5–7 day shipping) |
| Insurance accepted | No — cash pay only. FSA/HSA may be eligible (varies by plan provider). |
| Available everywhere? | No — injectable GLP-1s are not available in all 50 states |
| Cancellation | Cancel anytime to stop future renewals. Plans are paid upfront; refunds are limited. |
| Provider access | Licensed clinicians, 24/7 messaging, no in-person visits required |
| Company | Hims & Hers Health, Inc. — publicly traded (NYSE: HIMS), LegitScript certified |
Pricing verified on Hims.com, March 2026. Plans require upfront payment for the selected plan length.
Who Is Hims GLP-1 Actually Best For?
Not every GLP-1 provider fits every person. Here’s the honest breakdown of who Hims works well for — and who should look elsewhere.
- Want GLP-1 access without the insurance maze. No prior authorization battles, no claim denials, no pharmacy phone tag. You pay a known price, and medication ships to you.
- Value privacy and convenience. Everything happens online — no waiting room, no awkward conversation, no time off work.
- Are comfortable managing your own journey. 24/7 messaging access to providers, but no weekly coaching calls or structured meal plans.
- Want options. Three tiers: oral medication kits, compounded GLP-1 injectables, and branded FDA-approved medications.
- Need insurance to cover the cost. Hims doesn’t bill insurance. Period. Look into providers that work with insurance.
- Want structured coaching and behavioral support. Noom Med or a dedicated weight management clinic will serve you better.
- Only want FDA-approved, brand-name medication. Hims’ lowest-priced option is compounded, not FDA-approved. Branded options are significantly more expensive.
- Are uncomfortable with a prepaid commitment. Plans are paid upfront, and refunds are limited under their posted policies.
Switching from another provider?
If you’re already on a GLP-1 and considering switching to Hims, know that there’s no formal “dose transfer” process. You’ll go through the standard intake questionnaire. Our suggestion: mention your current medication, dosage, and how long you’ve been on it in the health history section so your new provider has the full picture.

What Do You Actually Get With Hims Weight Loss?
One thing that confused us during our research — and confuses a lot of people — is that Hims offers multiple weight loss programs under one umbrella. Not all of them involve GLP-1s. Here’s what each tier actually includes.
Tier 1: Oral Medication Kits (Not GLP-1)
These are daily pill combinations that may include metformin, bupropion, naltrexone, topiramate, and vitamin B12. Your provider selects the combination based on your health profile and goals.
These are not GLP-1 medications. They work through different mechanisms — reducing cravings, supporting metabolism, and addressing appetite from multiple angles. They’re a reasonable option if you can’t or don’t want to inject, or want a lower-cost starting point.
Starting price: $69/month with a 10-month plan ($690 upfront).
According to Hims’ published data, customers on oral kits combined with diet and exercise changes reported losing an average of 14.1 pounds (8.4% of body weight) over six months.
Tier 2: Compounded Semaglutide Injections (The Most Popular Option)
This is what most people mean when they search for “Hims GLP-1.” It’s a once-weekly self-injection of compounded semaglutide — the active compound that has driven the GLP-1 weight loss conversation.
Starting price: $199/month with a 6-month plan ($1,194 upfront).
A few critical things to understand about compounded semaglutide:
It is not FDA-approved as a finished product. The FDA has not reviewed compounded semaglutide for safety, effectiveness, or manufacturing quality. This is true of compounded GLP-1s from any provider, not just Hims. The FDA has a published page specifically addressing their concerns about unapproved GLP-1 drugs used for weight loss. (Source: FDA.gov, “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”)
Hims compounds through their own affiliated pharmacy. In 2024, Hims acquired MedisourceRx, a licensed 503B outsourcing facility in California. This means they have more direct control over their compounding supply chain than many competitors who rely on third-party pharmacies.
We cannot call it “the same as” Wegovy or Ozempic. The FDA issued a warning letter to Hims & Hers in September 2025, specifically objecting to marketing language that positioned compounded semaglutide as equivalent to branded FDA-approved products. It isn’t. Different manufacturing, different formulation, different regulatory oversight. We want to be clear about that.
What we can say: Hims’ own data from 13,458 customers on compounded GLP-1 treatment plans (combined with reduced-calorie diet and exercise) showed an average self-reported weight loss of 20.9 pounds — about 10.3% of initial body weight — within six months. 75% of those customers stayed on treatment at the six-month mark.
Tier 3: Branded GLP-1 Medications (FDA-Approved)
Hims also offers access to FDA-approved medications, including:
- Zepbound (tirzepatide) — FDA-approved for chronic weight management. Zepbound can be prescribed by any licensed clinician; note that Eli Lilly has publicly stated it has no affiliation with Hims & Hers. Pricing is significantly higher than compounded options.
- Generic liraglutide — Starting at $299/month with a 12-month plan ($3,588 upfront).
- Other branded options — Pricing and availability vary. Check the Hims website for current options.
Note on Wegovy: Novo Nordisk terminated its direct partnership with Hims in June 2025 and filed a federal lawsuit against the company in February 2026 over compounding practices. Wegovy availability through Hims may be limited or changing. Always verify current availability before enrolling.
What’s Included Beyond Medication
- Free initial medical assessment (~10–15 min)
- Licensed provider review & prescription
- 24/7 messaging with providers at no extra cost
- Personalized dosage adjustments
- Anti-nausea medication (if eligible)
- In-app educational content
- Discreet home delivery
- No separate membership fee
- Lab work ($75–$100 if provider requests it)
- Insurance billing
- In-person visits or video consultations
- Structured coaching or meal planning
- Food or supplements

How Much Does Hims GLP-1 Actually Cost? (The Real Numbers)
This is where most review sites do you a disservice. They say “starting at $199/month” and move on. That’s technically true — but it’s not the whole story.
Hims uses prepaid plans. The per-month price they advertise is what you get if you commit to a longer plan and pay the full amount upfront. Here’s what that actually looks like in real dollars.
Compounded Semaglutide Injections
| Plan Length | Monthly Rate | What You Pay Today |
|---|---|---|
| 6 months | $199/mo | $1,194 |
| 3 months | Higher (varies) | Verify on Hims.com |
| Shorter plans | Higher per month | Exact pricing shown at checkout |
Oral Medication Kits
| Plan Length | Monthly Rate | What You Pay Today |
|---|---|---|
| 10 months | $69/mo | $690 |
| Shorter plans | Higher per month | Verify on Hims.com |
Branded Medications
| Medication | Starting Price | Commitment |
|---|---|---|
| Generic liraglutide | $299/mo | 12-month plan, $3,588 upfront |
| Zepbound (tirzepatide) | Varies | Check current pricing |
| Other branded GLP-1s | Varies | Check current pricing |
Pricing verified on Hims.com, March 2026. Prices depend on medication type, plan length, and availability. Always verify current pricing before enrolling.
What This Means in Practical Terms
The most popular option — compounded semaglutide injections on a 6-month plan — works out to about $6.63 per day. That’s less than most people spend on their morning coffee run.
For context: brand-name Wegovy without insurance runs $1,000–$1,500+ per month. Even with some of the newer discount programs, out-of-pocket costs for branded GLP-1s are typically 3–5x higher than what Hims charges for compounded.
FSA/HSA may be eligible. According to Hims, weight loss treatment plans may qualify as eligible medical expenses for FSA and HSA reimbursement — though eligibility varies by plan provider. That means you may be able to pay with pre-tax dollars, effectively reducing the real cost by 20–30% depending on your tax bracket. Check with your plan administrator to confirm.
The Prepaid Model: Our Honest Take
Let’s address this directly because it’s the #1 concern we see in reviews.
Yes, you’re paying for multiple months upfront. Yes, refunds are limited — Hims’ posted policies handle refund requests on a case-by-case basis, and cancelling stops future renewals but may not stop an order already in process. If you have a terrible reaction in week two and want to stop, you may not get your money back for future months.
Here’s the context that most reviews leave out: that prepaid structure is exactly what makes the $199/month price possible. Shorter plans cost significantly more per month. And the data suggests most people don’t regret the commitment — Hims reports a 75% retention rate at six months, meaning three out of four customers stay on treatment through the full initial plan.
The upfront commitment also creates a behavioral advantage that’s easy to overlook. GLP-1 medications work best with consistent dosing. People who go month-to-month are more likely to skip months, take breaks, or stop early — all of which lead to worse results and more side effects when restarting. The prepaid plan keeps you on track, which is exactly what the medication needs to work.
Our recommendation: If you’re nervous about the commitment, start with the shortest plan available. Pay more per month, but give yourself a lower-risk window to see how your body responds. If it’s working — and for most people, it does — you can lock in the longer plan on your next cycle.
Hims
From $199/mo ($6.63/day)
How Do You Sign Up for Hims GLP-1?
The process is designed to be fast. Here’s exactly what happens, step by step.
Complete the online assessment (~10–15 minutes)
You'll answer questions about your health history, current medications, weight, height, lifestyle, and goals. No blood work is required to get started. You can optionally upload existing lab results if you have them.
Provider review (24–48 hours)
A licensed clinician trained in weight management reviews your information and determines whether GLP-1 treatment is clinically appropriate for you. Some states require a brief video call at this stage — most don't.
Choose your plan
If you qualify, your provider prescribes a treatment plan. You select your medication type (oral kit, compounded injectable, or branded) and plan length.
Pay and receive
You pay for the selected plan upfront. Medication ships in discreet packaging and typically arrives within 5–7 business days. Injectable plans include everything you need — medication vials, syringes, alcohol swabs, and step-by-step injection guidance.
Start treatment + ongoing support
Begin your medication following the included instructions and your provider's dosing schedule. From here, you have 24/7 messaging access to providers for questions, side effect management, or dosage adjustments — all at no extra cost.
What to Prepare Before You Start
A few practical tips that’ll save you time:
- Know your height and weight. You’ll need exact numbers for the BMI calculation that determines eligibility.
- Have your medication list handy. The questionnaire asks about everything you currently take — prescription, over-the-counter, supplements.
- Think about your health history. Thyroid conditions, diabetes, pancreatitis, eating disorders, kidney issues — the provider needs a complete picture.
- Decide on your budget. Know which tier fits your financial situation before you get to the payment screen.
- Optional but helpful: If you have recent blood work (within the last 6–12 months), upload it during the assessment.
Who Qualifies?
According to Hims, you’re generally eligible if you:
- Have a BMI of 30 or higher — or 27+ with at least one weight-related health condition (like high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, or PCOS)
- Are 18 years or older
- Are not pregnant or planning to become pregnant
- Have no personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Your provider makes the final eligibility determination based on your individual health profile. Not sure if you qualify? Try our GLP-1 BMI eligibility calculator.
Questions Worth Asking Your Hims Provider
Once you’re matched with a provider, you can message them through the app. Here are questions worth asking early on:
- “Based on my health profile, do you recommend starting with the compounded injectable or the oral kit?”
- “What dose am I starting at, and what’s the expected titration schedule?”
- “What should I do if nausea becomes severe in the first few weeks?”
- “Are there any interactions with my current medications I should watch for?”
- “At what point should we reassess my treatment plan if I’m not seeing results?”
Good providers appreciate engaged patients. Asking these questions doesn’t just get you better answers — it signals that you’re serious, which tends to improve the quality of care you receive.
Hims GLP-1 Results: How Much Weight Can You Realistically Lose?
This is the question behind the question. Every person searching for Hims GLP-1 reviews wants to know: will this actually work for me?
What the Data Shows
Hims’ own customer data (published July 2025):
- Customers on compounded GLP-1 injections reported losing an average of 20.9 pounds (10.3% of initial body weight) within six months
- Customers on oral medication kits reported losing an average of 14.1 pounds (8.4% of body weight) within six months
- 75% of customers remained on their treatment plan at six months
- 97% reported improvement in their overall health
- 59% reported improvement in at least one other health condition
Important context: These numbers are based on self-reported data from 13,458 customers on personalized treatment plans that included medication plus a reduced-calorie diet and exercise. This is company-published data, not independently verified clinical trial data. Individual results vary.
Published clinical trial data (branded semaglutide):
The landmark STEP 1 trial, published in the New England Journal of Medicine (Wilding et al., 2021), showed that adults taking 2.4mg weekly Wegovy (branded semaglutide) lost an average of approximately 15% of their body weight over 68 weeks. Those on placebo lost 2.4%. More recent long-term data has shown these results can be sustained over four years with continued treatment.
Note: Those trials studied FDA-approved branded semaglutide (Wegovy), not compounded versions. We cannot directly extrapolate clinical trial results to compounded products.
What Real Customers Say
We combed through thousands of reviews on Trustpilot (7,800+ reviews as of our last check), Reddit threads, and Hims’ own platform. Here are three representative experiences:
Major Results
One Hims user reported going from XL shirts to Medium, describing it as a “wild feeling to never have that urge to snack or want a second helping.” He also reported significantly increased energy levels. (Source: Hims.com customer review. Note: Hims discloses these are paid testimonials.)
Practical Experience
A Trustpilot reviewer described Semaglutide+ from Hims as “instrumental in my weight loss journey,” praising the support personnel and calling the pricing “fair in today’s market.” (Source: Trustpilot, verified reviewer)
More Cautious Experience
On Reddit, some users report slower results or frustrating side effects, particularly nausea in the first few weeks. One poster noted that results weren’t dramatic at first but improved significantly after the initial adjustment period. The common thread in negative reviews: the first 2–4 weeks are the hardest.
Realistic Timeline: What to Expect When
Reduced appetite is usually the first thing you notice. Cravings quiet down. You might lose 3–7 pounds, though some of this is water weight. Side effects — mainly nausea — are most common here. This is the "push through it" phase.
Your body starts adjusting. Nausea typically decreases. Weight loss becomes more consistent. "Food noise" — that constant background hum of thinking about eating — starts to fade. Many people describe this as the turning point.
Steady weight loss. Clothes are fitting differently. Energy is up. You're likely on a higher dose by now and the appetite-suppressing effect is fully kicking in.
This is where the average 20-pound loss milestone hits for most injectable GLP-1 users. The change is visible. People in your life start noticing.
Continued gradual weight loss or weight maintenance, depending on where you started and your goals. Published research shows that stopping semaglutide is associated with weight regain in many patients (Rubino et al., JAMA, 2021). This isn't a 3-month fix — it's a sustained approach.
Hims GLP-1 Side Effects: What’s Normal and What’s Not
We’re not going to sugarcoat this. GLP-1 medications come with side effects, and you should know exactly what to expect.

Common Side Effects (Most People Experience At Least One)
Nausea is the big one. It’s the most commonly reported side effect across all GLP-1 medications — branded and compounded alike. It’s usually worst in the first 2–4 weeks and when your dose increases. It’s uncomfortable but it’s temporary for most people.
Other common effects include:
- Decreased appetite (this is the mechanism working — it’s a feature, not a bug)
- Diarrhea or constipation (GI system adjusting)
- Stomach pain or bloating
- Headache
- Fatigue during the initial adjustment
Experiencing nausea? See our GLP-1 nausea relief guide and constipation relief guide.
What Hims Does About Side Effects
This is actually one area where Hims earns points. Their approach includes:
- Anti-nausea medication included at no extra cost for eligible patients
- Gradual dose titration — your provider starts you at a lower dose and increases slowly, specifically to reduce nausea and GI issues
- 24/7 provider messaging — if side effects are bothering you, you don’t have to wait for an appointment. Message your provider anytime
Less Common But Serious (When to Get Medical Help)
Seek medical attention immediately if you experience:
- Severe, persistent abdominal pain (could indicate pancreatitis)
- Allergic reaction symptoms: facial swelling, difficulty breathing, severe rash
- Vision changes (particularly if you’re diabetic)
- Symptoms of gallbladder problems: upper right abdominal pain, fever, jaundice
- Symptoms of kidney problems: significantly decreased urination, leg swelling
The FDA Boxed Warning (This Applies to ALL Semaglutide Products)
Semaglutide — including branded Wegovy and Ozempic — carries a boxed warning about thyroid C-cell tumors that were observed in animal studies. You should not use any semaglutide-based treatment if you or a family member have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Your Hims provider screens for this during the intake process. (Source: FDA prescribing information for Wegovy)
Our Take on the Side Effect Reality
Here’s what we tell people who are nervous about side effects: the nausea is real, it’s the #1 complaint, and pretending otherwise would insult your intelligence. But it’s also temporary for the vast majority of users. The personalized dosing approach that Hims uses — starting low and titrating up — exists specifically to make the adjustment period tolerable.
Think of it this way: you’re going to feel a little rough for 2–4 weeks. On the other side of that adjustment period, you get a medication that fundamentally changes your relationship with food — the constant hunger, the cravings, the “food noise” that’s been sabotaging every diet you’ve ever tried. Most people who push through those first few weeks say the same thing: it was worth it.
Check Your Eligibility on HimsThe Biggest Downside of Hims GLP-1 (And Why It Might Not Matter)
Every honest review needs to tell you the worst part. Here it is.
The prepaid plan structure is the biggest point of friction. You’re committing $1,194+ before you know how your body will respond to the medication. Refunds are limited under Hims’ policies, so if you have a severe reaction early on, you may not recover that cost. Some users have also reported frustration with the cancellation process — not that they couldn’t cancel, but that navigating it wasn’t as smooth as they expected.
This is real, and we wouldn’t be doing our job if we glossed over it.
Now here’s the part most people don’t consider: that structure is also working in your favor in ways that aren’t obvious.
First, it’s what keeps the price at $199/month. Hims offers lower rates for longer commitments because it reduces their churn costs and ensures medication supply. If you want shorter-term flexibility, you can have it — but you’ll pay more per month.
Second, and more importantly, the commitment itself improves your results. Clinical data on GLP-1 therapy consistently shows that consistent, sustained treatment produces the best outcomes. People who take GLP-1s sporadically — a month on, a month off — tend to have more side effects (your body keeps re-adjusting) and less weight loss. The prepaid plan creates a natural structure that keeps you on track through the early discomfort and into the results phase.
And the numbers support this: 75% of Hims customers are still on treatment at six months. That’s not the retention rate of a product people regret buying. That’s the retention rate of something that’s working.
Is Compounded Semaglutide From Hims Safe? (The Novo Nordisk Situation Explained)
If you’ve searched for Hims GLP-1 reviews in 2026, you’ve almost certainly come across headlines about lawsuits, FDA warnings, and Novo Nordisk drama. Let us break down what actually happened and what it means for you.
The Timeline
Hims begins prescribing compounded GLP-1 medications for weight loss.
Hims airs a Super Bowl ad promoting affordable weight loss treatment. Novo Nordisk responds with print ads in the New York Times and USA Today questioning the safety of compounded GLP-1s.
The FDA declares the semaglutide injectable shortage resolved, meaning the regulatory basis for compounding semaglutide became more complicated.
Novo Nordisk partners with Hims to offer branded Wegovy directly through the platform — a surprising truce.
Novo terminates the partnership after approximately eight weeks, accusing Hims of continuing to sell compounded products alongside Wegovy and engaging in "deceptive marketing." Hims stock fell about 22% in U.S. premarket trading.
The FDA issues a warning letter to Hims & Hers, objecting to marketing language that positioned compounded semaglutide as equivalent to FDA-approved branded products. (Source: FDA Warning Letters, Hims & Hers Health Inc., 09/09/2025)
Novo Nordisk files a federal patent infringement lawsuit against Hims, seeking to permanently block the company from selling compounded semaglutide. The FDA separately refers Hims to the Department of Justice. (Source: Reuters, February 2026)
Reuters reports the FDA has sent warning letters to 30 telehealth firms over misleading marketing of compounded GLP-1 drugs — Hims is one of many.
What This Actually Means for You
Here’s how we think about this as researchers who’ve been covering this space for over a year:
The legal battle is between two corporate giants with billions at stake. Novo Nordisk has a commercial interest in protecting its branded products (Wegovy and Ozempic generate tens of billions in annual revenue). Hims has a commercial interest in maintaining its compounded product line. Both sides have financial motivation.
The FDA’s concerns are real and worth understanding. The FDA has specifically flagged issues with compounded GLP-1 products including: dosing inconsistencies, questions about ingredient sources, temperature and shipping integrity, and marketing that overstates equivalence to FDA-approved products. These are legitimate safety considerations. (Source: FDA.gov, “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”)
Compounded GLP-1 use has expanded rapidly across telehealth platforms. Hims’ published outcomes dataset alone includes 13,458 customers showing weight loss results and a 75% retention rate at six months. Hims compounds through MedisourceRx, their own licensed 503B outsourcing facility, and may also use licensed pharmacy partners — giving them more supply chain oversight than many competitors.
This is an evolving situation. The outcome of the Novo lawsuit, the FDA enforcement actions, and potential Congressional regulation could change compounded GLP-1 availability in the coming months.
For a deeper dive into this topic, read our full guide: Is Compounded Semaglutide Safe?
Our Recommendation
If the regulatory uncertainty around compounding is genuinely concerning to you, that’s a completely valid reaction. In that case, consider Hims’ branded medication options (Zepbound, generic liraglutide) or speak with your doctor about an FDA-approved prescription filled through a traditional pharmacy.
If you’re comfortable with the tradeoff — lower cost through compounding, with the understanding that it’s not FDA-approved as a finished product — then Hims is one of the more established, transparent providers in this space. They’re a publicly traded company with SEC reporting obligations, LegitScript certification, and an in-house pharmacy operation.
This is ultimately a personal risk-tolerance decision. Our job is to give you the information to make it with open eyes.
Hims vs. Other Providers: Who Wins for Which Person?
We’re not going to turn this into a generic “best GLP-1 providers” list — you can find that on our best GLP-1 online programs page. But since comparing Hims to alternatives is one of the top reasons people search for reviews, here’s a focused comparison.
| Feature | Hims | Ro | Found | Noom Med |
|---|---|---|---|---|
| Compounded GLP-1 price | From $199/mo | From $349/mo | Varies | Varies |
| Branded GLP-1s available | Zepbound, liraglutide, others | Wegovy | Limited | Wegovy, Zepbound |
| Oral (non-GLP-1) options | From $69/mo | None | Yes | Yes |
| Insurance accepted | No | Partial | Partial | Some plans |
| Coaching / behavioral support | App content only | Minimal | Coach included | Full coaching program |
| Lab work required | No (optional) | $75 metabolic test | Varies | Varies |
| 24/7 provider messaging | Yes | Yes | Yes | Yes |
| Prepaid plans | Yes (limited refunds) | Yes | Varies | Varies |
Quick Picks by Scenario
If your #1 priority is affordable GLP-1 access: Hims offers one of the lowest prices among major national telehealth platforms for compounded semaglutide, and the oral kit option at $69/month is one of the cheapest weight loss medication programs available. There are smaller providers (MEDVi, GobyMeds) with even lower starting prices, but you’re trading brand recognition and infrastructure for cost savings.
If you want coaching and accountability: Noom Med is the standout here. Their program wraps GLP-1 prescribing inside a full behavioral change platform with psychology-based lessons, coaching, and habit support. It costs more, but if you know you need structure beyond just medication, it’s worth it.
If you want insurance to cover it: Neither Hims nor most telehealth platforms reliably accept insurance for compounded GLP-1s. For insurance-covered weight loss treatment, your best bet is usually a direct conversation with your primary care doctor or an obesity medicine specialist who can prescribe FDA-approved branded medications covered by your plan.
If you want the simplest, fastest path to GLP-1 treatment: Hims wins on speed and simplicity. Their signup-to-medication pipeline is streamlined, the pricing is transparent, and there’s no metabolic test requirement slowing things down.
Hims
From $199/mo (compounded semaglutide)
Can You Cancel Hims GLP-1?
Yes. Let’s be specific about how it works.
You can cancel your Hims subscription at any time through your account dashboard. There’s no monthly membership fee to cancel — the only charge is the medication plan itself.
But here’s the important nuance: your medication plan is paid upfront. Cancelling stops future renewals, but it may not stop an order already being processed or shipped. Refunds are limited and handled under Hims’ posted policies and terms. If you bought a 6-month plan and decide to stop after month 2, you likely won’t get the remaining four months refunded. You can stop taking the medication, but you’ve already paid.
What some users have reported: A handful of Trustpilot and Reddit reviews mention difficulty navigating the cancellation flow, or unexpected renewal charges if they didn’t cancel before the automatic renewal date. These complaints aren’t universal — but they’re common enough that we want to flag them.
Our Practical Advice
- If you’re nervous about commitment, start with the shortest plan available (even though the per-month rate is higher). Test your body’s response before locking into 6+ months.
- Set a calendar reminder 2 weeks before your plan renews so you have time to decide whether to continue.
- Cancel through your account dashboard before the renewal date, not after. Once a new plan charges, refunds are limited.
- Save screenshots of your cancellation confirmation, just in case.
How to Verify What Hims Sends You (5-Minute Safety Check)
One of the smartest things you can do when ordering any medication online — from Hims or anyone else — is verify what you receive. Here’s a quick checklist we put together based on the FDA’s published guidance for consumers using compounded medications.

When your package arrives, check for:
- Proper labeling. Your medication should include: the pharmacy name and license number, your full name, the prescribing provider’s name, the medication name and concentration, lot number, expiration date, and storage instructions.
- Cold chain integrity. Injectable semaglutide should arrive cold. If the package contains cold packs, check that they’re still cool to the touch. If your medication arrived warm or without cold packaging, contact Hims before using it — temperature-compromised medications may not work properly or could be unsafe.
- Visual inspection. The solution should be clear and colorless. If it’s cloudy, discolored, or contains particles, don’t use it. Contact Hims for a replacement.
- Consistent dosing information. Your dosing instructions should match what your provider communicated. If there’s any discrepancy between what you were told and what the label says, message your provider through the app before injecting.
- Pharmacy verification. You can verify that the dispensing pharmacy is licensed by checking your state’s Board of Pharmacy website. Hims has built in-house pharmacy operations (including MedisourceRx) and may also use licensed pharmacy partners depending on the product. The dispensing pharmacy will be listed on your medication label.
If something seems off: Contact Hims support immediately. If you have a safety concern about any medication you’ve received, you can also report it to the FDA’s MedWatch program (FDA.gov/MedWatch).
This 5-minute check gives you peace of mind and puts you in a stronger position than 99% of online pharmacy customers. It’s one of the simplest things you can do to protect yourself. For a more comprehensive guide, see: How to Take GLP-1 Safely.
Is Hims GLP-1 Available in My State?
Hims GLP-1 injectable treatments are not available in all 50 states. Availability depends on state pharmacy regulations, provider licensing, and compounding laws — all of which are in flux right now.
GLP-1 options aren’t available in every state, and the list of where they’re offered changes frequently. The fastest way to confirm is to start the Hims assessment and enter your location.
If GLP-1 injectables aren’t available in your state, Hims may offer the oral medication kit as an alternative.
Our advice: Don’t guess. Enter your zip code during the Hims assessment process — it will tell you exactly what’s available where you live. State availability is one of the most rapidly changing aspects of the GLP-1 telehealth space right now, and any list we publish would be outdated within weeks.
Check Availability in Your State on HimsWhat About Hims GLP-1 Microdosing?
You may have seen “microdosing” language in Hims’ marketing. Let’s be direct about what this means and what it doesn’t.
“GLP-1 microdosing” generally refers to prescribing semaglutide at doses smaller than the standard FDA-approved titration schedule. The idea is that lower doses might provide appetite suppression with fewer side effects, making it accessible to a broader population.
Here’s what you should know: There is limited published clinical evidence specifically supporting the efficacy of GLP-1 “microdosing” as currently marketed by telehealth platforms. A STAT News investigation (November 2025) found no robust clinical evidence that sub-therapeutic GLP-1 doses produce meaningful long-term weight loss.
That doesn’t mean low-dose GLP-1 does nothing — all semaglutide dosing protocols begin with lower doses and titrate up. But the marketing of “microdosing” as a distinct, validated approach goes beyond what current evidence supports.
Our take: If your Hims provider recommends starting at a lower dose and titrating up, that’s standard medical practice and makes sense. But if you’re specifically seeking “microdosing” as a standalone long-term strategy, have an honest conversation with your provider about what the evidence actually shows. See also: Microdosing Tirzepatide: What the Evidence Says.
What Happens When You Stop Taking GLP-1s?
We believe in being upfront about this because it affects the long-term decision to start.
Published clinical research shows that stopping GLP-1 medications is associated with significant weight regain in many patients. A study published in JAMA found that participants regained a substantial portion of lost weight within a year of discontinuing semaglutide (Rubino et al., 2021).
This makes biological sense. GLP-1 medications work by reducing appetite and slowing gastric emptying. When you stop, those effects fade, and the appetite signals that drove weight gain before treatment can return.
What this means practically: GLP-1 therapy is generally considered a long-term treatment, similar to blood pressure or cholesterol medication. It’s not a 3-month “reset” — the benefits last while you’re on it.
The hopeful part: Some people are able to successfully taper off GLP-1s by establishing strong exercise habits, high-protein nutrition routines, and behavioral patterns during treatment that persist after stopping. This is one reason programs that include behavioral support alongside medication (like Noom Med) can offer long-term advantages. It’s also why Hims includes nutritional and behavioral content in their app — the goal is to build habits while the medication gives you a window of reduced appetite to practice them.
Always discuss any plan to stop or reduce your medication with your provider. Abrupt discontinuation isn’t recommended. Read more: What Happens When You Stop Taking GLP-1.
How We Reviewed Hims GLP-1
We think you should know how we arrived at our conclusions.
- Pricing verification. We verified all pricing directly on Hims.com on the date shown at the top of this page. We calculate and display total upfront costs — not just the per-month marketing rate — so you know the real financial commitment.
- Review analysis. We analyzed 7,800+ reviews on Trustpilot, cross-referencing patterns with Reddit discussions (r/HimsWeightloss, r/glp1, r/semaglutide) and independent review sites. We looked for recurring themes in both positive and negative feedback.
- Clinical evidence review. We reviewed the published STEP clinical trials for branded semaglutide (Wilding et al., NEJM, 2021), Hims’ own published customer outcome data (July 2025 press release), and FDA guidance documents on compounded GLP-1 medications.
- Competitive comparison. We compared Hims against six other major telehealth weight loss providers across pricing, medication options, clinical support quality, and user experience metrics.
- Regulatory monitoring. We actively track the FDA, FTC, and legal landscape around compounded GLP-1s, including the September 2025 FDA warning letter to Hims & Hers and the February 2026 Novo Nordisk lawsuit.
- Affiliate disclosure. We are an affiliate of Hims and earn a commission if you sign up through our links. We disclose this upfront. Our methodology doesn’t change based on affiliate status — we’ve recommended against Hims for specific user profiles in this review (see the “Who Hims is NOT for” section) where other providers are a better fit. We believe earning your trust is worth more than any single commission.
Hims GLP-1 FAQ: Every Question Answered
Frequently Asked Questions
The Bottom Line: Should You Try Hims GLP-1?
You’ve made it through every section. You’ve seen the real pricing, the verified data, the honest downsides, and the full regulatory context. Here’s our final take.
Hims is one of the most accessible, well-priced GLP-1 platforms available in 2026. It’s not perfect — the prepaid commitment is real, the compounding controversy is ongoing, and you won’t get the kind of hands-on coaching that some people need. We’ve been clear about those tradeoffs throughout this page.
But for the right person — someone who wants convenient, affordable, privacy-first access to GLP-1 treatment and is comfortable with a digital-first healthcare experience — Hims delivers. They’re a publicly traded company with an in-house pharmacy, transparent pricing, and customer outcome data that shows real results.
Here’s what we know: you didn’t land on this page by accident. You’ve been thinking about this. You’ve been reading reviews, comparing options, and looking for someone to give you a straight answer. We’ve tried to do that here — with verification, sources, and honesty about both the good and the bad.
The decision is yours. The data is on your side. And the assessment is free.
Ready to See If Hims Is Right for You?
Hims’ free online assessment takes 10–15 minutes. A licensed provider reviews your health profile and recommends the best option for your situation. No obligation, no appointment needed.
See If You Qualify for Hims GLP-1 — Free AssessmentAffiliate link — we may earn a commission at no extra cost to you.
Sources
- Wilding JPH, et al. (2021). “Once-weekly semaglutide in adults with overweight or obesity.” New England Journal of Medicine. DOI: 10.1056/NEJMoa2032183
- Hims & Hers Health, Inc. (July 2025). “Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care.” Press release.
- U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” FDA.gov
- U.S. Food and Drug Administration. FDA Warning Letter: Hims & Hers Health, Inc. (September 9, 2025).
- U.S. Food and Drug Administration. Prescribing information for Wegovy (semaglutide injection). AccessData.FDA.gov
- Novo Nordisk. (June 2025). “Novo Nordisk terminates collaboration with Hims & Hers Health, Inc.” Press release.
- Novo Nordisk v. Hims & Hers Health, Inc. (February 2026). Federal patent infringement lawsuit.
- Hims & Hers Health, Inc. Q4 2025 Earnings Call (February 2026).
- Rubino DM, et al. (2021). “Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance.” JAMA. DOI: 10.1001/jama.2021.3224
- Trustpilot. Hims.com reviews (7,800+ as of March 2026).
- LegitScript Certification Database.
- STAT News (November 2025). “Microdosing GLP-1 drugs: no clinical evidence it’s effective.”
- Reuters (March 2026). “US FDA warns 30 telehealth firms over misleading marketing of compounded GLP-1 drugs.”
- U.S. Food and Drug Administration. “FDA Intends to Take Action Against Non-FDA Approved GLP-1 Drugs.” Press Announcements.
- Eli Lilly and Company. “Statement: Lilly Has No Affiliation with Hims & Hers.” Investor Relations.
- Reuters (June 2025). “Novo Nordisk ends collaboration with Hims & Hers over weight-loss drug sale.”
- Reuters (February 2026). “Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies.”
Update Log
| Date | What Changed |
|---|---|
| March 2026 | Initial publication. Pricing verified on Hims.com. Regulatory status updated to reflect Novo Nordisk lawsuit and FDA warning letters. |
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight loss medication. GLP-1 medications carry risks and are not appropriate for everyone.
Affiliate Disclosure: This page contains affiliate links. We may earn a commission if you sign up through our links at no additional cost to you. This does not influence our editorial content.
Sources: FDA Wegovy prescribing information; Hims & Hers Health investor releases (Business Wire, July 2025); Trustpilot; Reddit (r/HimsWeightloss, r/semaglutide, r/glp1); Hims.com (verified March 2026); Reuters; STAT News.